agilon health financials
$78.15−1.74%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.42B | $1.57B | $1.44B | $1.39B | $1.53B | $1.52B | $1.45B | $1.48B | $1.60B | $1.06B | $1.14B |
| Gross profit | $107.1M | $65.0M | -$90.7M | -$67.6M | -$52.4M | $50.7M | -$38.3M | -$64.2M | $32.2M | $75.1M | -$94.9M | $36.8M |
| Gross margin | 7.2% | 4.6% | −5.8% | −4.7% | −3.8% | 3.3% | −2.5% | −4.4% | 2.2% | 4.7% | −9.0% | 3.2% |
| Operating income | $11.8M | $4.0M | -$193.8M | -$131.3M | -$116.0M | -$22.1M | -$108.1M | -$133.5M | -$43.3M | -$7.2M | -$164.3M | -$39.3M |
| Net income | $18.0M | $48.9M | -$188.9M | -$110.2M | -$104.4M | $12.1M | -$105.8M | -$117.6M | -$30.7M | -$6.1M | -$230.4M | -$31.4M |
| Net margin | 1.2% | 3.4% | −12.0% | −7.7% | −7.5% | 0.8% | −6.9% | −8.1% | −2.1% | −0.4% | −21.8% | −2.8% |
| Diluted EPS | $1.04 | $2.94 | $-3.91 | $-6.75 | $-6.31 | $0.73 | $-6.42 | $-7.25 | $-1.75 | $-0.25 | $-14.66 | $-2.00 |
| EBITDA | $18.6M | $10.8M | -$150.8M | -$123.8M | -$108.7M | -$15.2M | -$98.0M | -$127.3M | -$37.4M | -$1.3M | -$164.3M | -$34.0M |
| Operating cash flow | -$57.3M | $23.7M | -$20.5M | -$18.2M | -$35.1M | -$32.0M | $16.4M | -$7.7M | -$18.7M | -$47.8M | -$61.2M | -$13.0M |
| Free cash flow | -$60.7M | $20.6M | -$23.5M | -$21.3M | -$38.3M | -$35.8M | $13.2M | -$11.2M | -$22.0M | -$50.9M | -$65.1M | -$17.1M |
| Diluted shares | 17.2M | 16.7M | 48.3M | 16.6M | 16.6M | 16.5M | 16.5M | 16.5M | 16.5M | 16.4M | 15.7M | 16.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $107.2M | $140.0M | $173.7M | $171.7M | $171.4M | $136.9M |
| Short-term investments | $78.4M | $91.4M | $111.4M | $139.2M | $155.6M | $230.1M |
| Total debt | $30.3M | $30.0M | $35.0M | $35.0M | $34.9M | $34.9M |
| Total assets | $1.59B | $1.50B | $1.27B | $1.60B | $1.71B | $1.93B |
| Total liabilities | $1.36B | $1.32B | $1.14B | $1.29B | $1.30B | $1.43B |
| Shareholders' equity | $227.5M | $181.4M | $126.7M | $306.1M | $408.9M | $500.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology